Ifp Advisors, Inc Mannkind Corp Transaction History

Ifp Advisors, Inc

  • $2.42 Billion
  • Q2 2024

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Sep 06, 2022
BUY
$2.67 - $4.77 $3,257 - $5,819
1,220 New
1,220 $2,000
Q2 2022

Aug 12, 2022
SELL
$2.67 - $4.77 $3,257 - $5,819
-1,220 Closed
0 $0
Q1 2022

Sep 06, 2022
BUY
$2.62 - $4.45 $3,196 - $5,429
1,220 New
1,220 $4,000
Q3 2021

Oct 06, 2021
SELL
$3.89 - $5.48 $0 - $0
0 Closed
0 $0
Q2 2021

Jul 13, 2021
BUY
$3.61 - $5.45 $0 - $0
0 New
0 $0
Q1 2021

Apr 30, 2021
BUY
$3.14 - $6.14 $0 - $0
0 New
0 $0
Q4 2020

Jan 25, 2021
BUY
$1.79 - $4.04 $0 - $0
0 New
0 $0
Q3 2020

Oct 29, 2020
BUY
$1.56 - $2.08 $0 - $0
0 New
0 $0
Q2 2020

Aug 05, 2020
BUY
$0.94 - $2.21 $0 - $0
0 New
0 $0
Q1 2020

May 12, 2020
BUY
$0.84 - $1.76 $0 - $0
0 New
0 $0
Q4 2019

Jan 17, 2020
BUY
$1.14 - $1.49 $0 - $0
0 New
0 $0
Q3 2019

Nov 07, 2019
SELL
$1.04 - $1.44 $78 - $108
-75 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$1.14 - $2.25 $17 - $33
15 Added 25.0%
75 $0
Q3 2018

Oct 25, 2018
SELL
$1.01 - $2.19 $262 - $569
-260 Reduced 81.25%
60 $0
Q2 2018

Aug 07, 2018
BUY
$1.59 - $2.38 $190 - $285
120 Added 60.0%
320 $0
Q4 2017

Jan 24, 2018
SELL
$2.28 - $6.71 $4,019 - $11,829
-1,763 Reduced 89.81%
200 $0
Q2 2017

Jun 03, 2019
SELL
N/A
-2,800 Reduced 58.79%
1,963 $3,000
Q1 2017

Jun 03, 2019
BUY
N/A
4,688 Added 6250.67%
4,763 $7,000
Q1 2016

Jun 03, 2019
BUY
N/A
75
75 $0

Others Institutions Holding MNKD

# of Institutions
243
Shares Held
148M
Call Options Held
1.62M
Put Options Held
802K
View Full List

About MANNKIND CORP

MNKD Quotes by TradingView
  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.57B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email